Filing Flows › Biolargo (BLGO) › Q2 2026
Biolargo (BLGO) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 14, 2026
Biolargo (BLGO) reported revenue of $1.2M for the second quarter 2026 (Q2 2026), -55% from a year earlier and +12% from the quarter before. Operating margin was -298.7%, net loss $4.0M (320.5% of revenue).
Biolargo, Q2 2026: revenue $1.2M (-55% year over year), operating margin -298.7%, net loss $4.0M, operating cash flow −$3.1M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.2M | +12% | -55% |
| Operating profit | −$3.7M | — | — |
| Net earnings | −$4.0M | — | — |
| Operating cash flow | −$3.1M | — | — |
What changed
Revenue was $1.2M in Q2 2026, down 55% year over year and up 12% from the previous quarter. Service was the largest line at 66% of revenue. Product lost $1.6M year over year (down 79%), 104% of the total change.
Gross margin was 54.1%, up 2.9 points from Q2 2025. Operating costs exceeded revenue by $3.7M, an operating margin of -298.7%. Operating expenses grew 37% against a revenue fall of 55%. The fastest-growing cost line was Research & development (+103%). The quarter ended with a net loss of $4.0M, wider than the previous quarter's $3.4M loss. Minority interests bore $1.2M of it: to shareholders the quarter was a loss of $2.8M.
Operating cash flow was −$3.1M. Non-cash charges added back $31K of depreciation and $722K of share-based compensation. Working capital and other items added $191K.
Questions
What was Biolargo's revenue in the second quarter 2026?
Biolargo (BLGO) reported revenue of $1.2M for the second quarter 2026 (Q2 2026), -55% from a year earlier and +12% from the quarter before.
Was Biolargo profitable in the second quarter 2026?
Operating loss was $3.7M (-298.7% of revenue) and net loss $4.0M.
Source: Biolargo 10-Q on SEC EDGAR.